🔎 Trials Near Me

Akèy › Maladi selil fòs › Georgia

Etid klinik pou Maladi selil fòs nan Georgia

25 etid pou Maladi selil fòs ap chèche patisipan nan sit nan Georgia.

Vil nan Georgia

Tèks ofisyèl etid la (Anglè)

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

  • Augusta University Georgia, Augusta
  • WCG Sonar Clinical Research, Riverdale
Ap rekriteFaz 3
Laj 12 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT06439082

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

  • Emory University, Atlanta
  • Augusta University, Augusta
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07187973

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

  • Children's Healthcare Atlanta, Atlanta
Ap rekriteFaz 3
Laj 2 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT06609226

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  • Children's Healthcare Atlanta, Atlanta
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT06612268

Assessing Molecular Mechanisms and Effects of Music Therapy in Youth With Sickle Cell Disease Using Single-cell RNA-sequencing

  • Children's Healthcare of Atlanta, Atlanta
Ap rekrite
Laj 8 a 18 · Tout sèks · Mizajou Sep 10, 2026 · NCT07562451

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

  • Children's Center for Advanced Pediatrics, Atlanta
Ap rekriteFaz 2/3
Laj 12 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT05431088

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

  • Winship Cancer Institute of Emory University, Atlanta
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT06481306

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Comprehensive Bleeding Disorders Center at Emory University and Children's Healthcare of Atlanta, Atlanta
  • Emory/Children's Health Care of Atlanta, Atlanta
  • Memorial Health University Medical Center, Savannah
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Aug 17, 2026 · NCT04398628

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

  • Arthur M. Blank Hospital-Children's Healthcare of Atlanta, Atlanta
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT06699849

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

  • Arthur M. Blank Hospital- Children's Healthcare of Atlanta, Atlanta
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT07224360

Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

  • Children's Healthcare fo Atlanta at Hughes Spalding, Atlanta
  • Children's Healthcare of Atlanta at Arthur M. Blank Hospital, Atlanta
Ap rekriteFaz 1/2
Laj 7 a 21 · Tout sèks · Mizajou Jul 29, 2026 · NCT02447874

Cooperative Assessment of Late Effects for SCD Curative Therapies

  • Emory University School of Medicine, Atlanta
Ap rekriteEtid obsèvasyon
Laj 4 a 65 · Tout sèks · Mizajou Jul 27, 2026 · NCT05153967

Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study

  • Augusta University Georgia, Augusta
Ap rekriteFaz 4
6 Months – 100 Years · Tout sèks · Mizajou Jun 8, 2026 · NCT04657822

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

  • Children's Healthcare of Atlanta (MRD-HCT), Atlanta
Ap rekriteEtid obsèvasyon
Laj 3 a 20 · Tout sèks · Mizajou Jun 4, 2026 · NCT06941389

Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease

  • Children's Healthcare of Atlanta, Atlanta
Ap rekriteFaz 1/2
Laj 12 a 45 · Tout sèks · Mizajou Jun 4, 2026 · NCT07252050

Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease

  • Emory University, Atlanta
Ap rekriteFaz 4
Laj 18 a 50 · Fanm · Mizajou May 28, 2026 · NCT06665997

A Socio-ecological Approach for Improving Self-management in Adolescents With SCD

  • Children's Healthcare of Atlanta, Atlanta
Ap rekrite
Laj 13 a 21 · Tout sèks · Mizajou May 11, 2026 · NCT06290401

Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease

  • Site # 8400006, Atlanta
  • Site # 8400002, Atlanta
Ap rekriteFaz 3
Laj 2 a 17 · Tout sèks · Mizajou Apr 15, 2026 · NCT07247188

Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease

  • Grady Health System, Atlanta
Ap rekriteFaz 4Volontè an sante akeyi
Laj 18 ak plis · Fanm · Mizajou Feb 18, 2026 · NCT06979492

A Long-term Follow-up Study in Patients Who Received BEAM-101

  • Children's Healthcare of Atlanta - Aflac Cancer and Blood Disorders Center- Egleston, Atlanta
Ap rekriteEtid obsèvasyon
Laj 14 a 37 · Tout sèks · Mizajou Jan 28, 2026 · NCT07373639

Trans-auricular Nerve Stimulation as an Innovative Approach to the Treatment of Pain in Pediatric Patients Suffering From Sickle Cell Disease

  • Children's Hospital of Atlanta: Eagelston, Atlanta
Ap rekrite
Laj 7 a 18 · Tout sèks · Mizajou Jan 26, 2026 · NCT07090668

Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • Augusta University, Augusta
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jan 9, 2026 · NCT01245179

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

  • Children's Healthcare of Atlanta, Atlanta
Ap rekrite
Laj 16 a 30 · Tout sèks · Mizajou Jan 7, 2026 · NCT06374238

Integrative Training Program for Pediatric Sickle Cell Pain

  • Children's Healthcare of Atlanta, Atlanta
  • Arthur M. Blank Hospital | Children's Healthcare of Atlanta, Atlanta
Ap rekrite
Laj 12 a 18 · Tout sèks · Mizajou Nov 14, 2025 · NCT06691867

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

  • Augusta University, Augusta
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 22, 2025 · NCT06385886

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.